The National Comprehensive Cancer Network Oncology Research Program and Pfizer Global Medical Grants said they have awarded funding to nine projects that use clinical care pathways to implement quality improvement initiatives along the continuum of care for underserved patients with breast cancer.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
